Submitted:
30 May 2026
Posted:
01 June 2026
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
2.1. Study Design and Population
2.2. Eligible Population
2.3. Ethical Considerations

2.4. Sociodemographic and Lifestyle Assessment
2.5. Clinical Assessment
2.6. Food Hypersensitivity Assessment
2.7. Biochemical and Stool Analyses
2.8. Gastrointestinal Assessment and IBS Diagnosis
2.9. Dietary Assessment and Nutritional Status
2.10. Microbiological and Inflammatory Assessments
2.11. Statistical Analysis
3. Results
3.1. Study Population and Classification of Food Hypersensitivity
3.2. Sociodemographic Characteristics
3.3. Anthropometric, Clinical, and Lifestyle Characteristics
3.4. Biochemical and Microbiological Findings
3.5. Dietary Intake and Nutrient Adequacy
3.6. Distribution of Clinical Symptoms
3.7. Stress Levels
3.8. Association of Clinical, Biochemical, and Dietary Factors with Food Hypersensitivity
| Variables (model 1) | OR | 95% CI |
| Calprotectin (positive vs. negative) | 2.802 | 1.646–4.772 |
| Vitamin D serum level (µg/day) | 0.992 | 0.984–0.998 |
| Variables (model 2) | ||
| Calprotectin (positive vs. negative) | 3.385 | 1.869–6.132 |
| Vitamin D (µg/day) | 0.855 | 0.740–0.989 |
| Sugar (g/day) | 1.110 | 1.032–1.194 |
4. Discussion
5. Conclusions
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
References
- Hage G, Sacre Y, Haddad J, Hajj M, Sayegh LN, Fakhoury-Sayegh N. Food Hypersensitivity: Distinguishing Allergy from Intolerance, Main Characteristics, and Symptoms—A Narrative Review. Nutrients (2025) 17:1359. [CrossRef]
- Loh W, Tang MLK. The Epidemiology of Food Allergy in the Global Context. International Journal of Environmental Research and Public Health (2018) 15:2043. [CrossRef]
- Vassilopoulou E, Venter C, Roth-Walter F. Malnutrition and Allergies: Tipping the Immune Balance towards Health. J Clin Med (2024) 13:4713. [CrossRef]
- Meyer R, De Koker C, Skrapac A-K, Godwin H, Reeve K, Chebar-Lozinsky A, Shah N. A practical approach to vitamin and mineral supplementation in food allergic children - Meyer - 2015 - Clinical and Translational Allergy - Wiley Online Library. (2015). [CrossRef]
- Sova C, Feuling MB, Baumler M, Gleason L, Tam JS, Zafra H, Goday PS. Systematic review of nutrient intake and growth in children with multiple IgE-mediated food allergies. Nutr Clin Pract (2013) 28:669–675. [CrossRef]
- Skypala IJ, Taylor CF, Pallister A, Scadding GW. A Pilot Study to Evaluate the Dietary Intake of Adults Attending a Food Allergy Clinic, and Compare the Results Against the Final Diagnostic Outcome. Front Allergy (2021) 2:. [CrossRef]
- Kaganov B, Caroli M, Mazur A, Singhal A, Vania A. Suboptimal Micronutrient Intake among Children in Europe. Nutrients (2015) 7:3524–3535. [CrossRef]
- Kotchetkoff EC de A, de Oliveira LCL, Sarni ROS. Elimination diet in food allergy: friend or foe? J Pediatr (Rio J) (2024) 100:S65–S73. [CrossRef]
- Jomaa L, Hwalla N, Itani L, Chamieh MC, Mehio-Sibai A, Naja F. A Lebanese dietary pattern promotes better diet quality among older adults: findings from a national cross-sectional study | BMC Geriatrics. (2016). [CrossRef]
- Chafei H, El Harake MD, Toufeili I, Kharroubi SA. Knowledge, Attitudes, and Practices of Consumers on Food Allergy and Food Allergen Labeling: A Case of Lebanon. Foods (2023) 12:933. [CrossRef]
- Craig CL, Marshall AL, Sjöström M, Bauman AE, Booth ML, Ainsworth BE, Pratt M, Ekelund U, Yngve A, Sallis JF, et al. International Physical Activity Questionnaire: 12-Country Reliability and Validity. Medicine & Science in Sports & Exercise (2003) 35:1381. [CrossRef]
- Levenstein S, Prantera C, Varvo V, Scribano ML, Berto E, Luzi C, Andreoli A. Development of the perceived stress questionnaire: A new tool for psychosomatic research. Journal of Psychosomatic Research (1993) 37:19–32. [CrossRef]
- Drossman DA, Dumitrascu DL. Rome III: New Standard for Functional Gastrointestinal Disorders. Journal of Gastrointestinal and Liver Diseases (2006) 15:237–241.
- Aoun C, Bou Daher R, El Osta N, Papazian T, Khabbaz LR. Reproducibility and relative validity of a food frequency questionnaire to assess dietary intake of adults living in a Mediterranean country. PLoS One (2019) 14:e0218541. [CrossRef]
- U.S. Department of Agriculture & U.S. Department of Health and Human ServiceDietary Guidelines for Americans, 2020-2025. (9th ed) USDA/HHS (2020) https://www.dietaryguidelines.gov/.
- Tedner SG, Asarnoj A, Thulin H, Westman M, Konradsen JR, Nilsson C. Food allergy and hypersensitivity reactions in children and adults—A review. Journal of Internal Medicine (2022) 291:283–302. [CrossRef]
- Muraro A, Halken S, Arshad SH, Beyer K, Dubois AEJ, Du Toit G, Eigenmann PA, Grimshaw KEC, Hoest A, Lack G, et al. EAACI Food Allergy and Anaphylaxis Guidelines. Primary prevention of food allergy. Allergy (2014) 69:590–601. [CrossRef]
- Connors L, O’Keefe A, Rosenfield L, Kim H. Non-IgE-mediated food hypersensitivity. Allergy, Asthma & Clinical Immunology (2018) 14:56. [CrossRef]
- D’Auria E, Pendezza E, Leone A, Riccaboni F, Bosetti A, Borsani B, Zuccotti G, Bertoli S. Nutrient intake in school-aged children with food allergies: a case-control study. Int J Food Sci Nutr (2022) 73:349–356. [CrossRef]
- Conlon MA, Bird AR. The Impact of Diet and Lifestyle on Gut Microbiota and Human Health. Nutrients (2014) 7:17–44. [CrossRef]
- Halmos EP, Power VA, Shepherd SJ, Gibson PR, Muir JG. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology (2014) 146:67-75.e5. [CrossRef]
- Zingone F, Bertin L, Maniero D, Palo M, Lorenzon G, Barberio B, Ciacci C, Savarino EV. Myths and Facts about Food Intolerance: A Narrative Review. Nutrients (2023) 15:4969. [CrossRef]
- Pinto-Sanchez MI, Nardelli A, Borojevic R, De Palma G, Calo NC, McCarville J, Caminero A, Basra D, Mordhorst A, Ignatova E, et al. Gluten-Free Diet Reduces Symptoms, Particularly Diarrhea, in Patients With Irritable Bowel Syndrome and Antigliadin IgG. Clin Gastroenterol Hepatol (2021) 19:2343-2352.e8. [CrossRef]
- Vassilopoulou E, Feketea G, Konstantinou GN, Zekakos Xypolias D, Valianatou M, Petrodimopoulou M, Vourga V, Tasios I, Papadopoulos NG. Food Protein-Induced Allergic Proctocolitis: The Effect of Maternal Diet During Pregnancy and Breastfeeding in a Mediterranean Population. Front Nutr (2022) 9:. [CrossRef]
- Bjarnason I, Sherwood R. Fecal calprotectin: a significant step in the noninvasive assessment of intestinal inflammation. J Pediatr Gastroenterol Nutr (2001) 33:11–13. [CrossRef]
- Bischoff SC, Barbara G, Buurman W, Ockhuizen T, Schulzke J-D, Serino M, Tilg H, Watson A, Wells JM. Intestinal permeability--a new target for disease prevention and therapy. BMC Gastroenterol (2014) 14:189. [CrossRef]
- Fasano A. Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer. Physiol Rev (2011) 91:151–175. [CrossRef]
- Bischoff SC. “Gut health”: a new objective in medicine? BMC Med (2011) 9:24. [CrossRef]
- Aranow C. Vitamin D and the immune system. J Investig Med (2011) 59:881–886. [CrossRef]
- Prietl B, Treiber G, Pieber TR, Amrein K. Vitamin D and immune function. Nutrients (2013) 5:2502–2521. [CrossRef]
- Allen KJ, Koplin JJ, Ponsonby A-L, Gurrin LC, Wake M, Vuillermin P, Martin P, Matheson M, Lowe A, Robinson M, et al. Vitamin D insufficiency is associated with challenge-proven food allergy in infants. J Allergy Clin Immunol (2013) 131:1109–1116, 1116.e1–6. [CrossRef]
- Vassallo MF, Camargo CA. Potential mechanisms for the hypothesized link between sunshine, vitamin D, and food allergy in children. J Allergy Clin Immunol (2010) 126:217–222. [CrossRef]
- Zinöcker MK, Lindseth IA. The Western Diet–Microbiome-Host Interaction and Its Role in Metabolic Disease. Nutrients (2018) 10:. [CrossRef]
- Do MH, Lee E, Oh M-J, Kim Y, Park H-Y. High-Glucose or -Fructose Diet Cause Changes of the Gut Microbiota and Metabolic Disorders in Mice without Body Weight Change. Nutrients (2018) 10:761. [CrossRef]
- Thorburn AN, Macia L, Mackay CR. Diet, metabolites, and “western-lifestyle” inflammatory diseases. Immunity (2014) 40:833–842. [CrossRef]
- Barcik W, Boutin RCT, Sokolowska M, Finlay BB. The Role of Lung and Gut Microbiota in the Pathology of Asthma. Immunity (2020) 52:241–255. [CrossRef]
| Classification | Participants frequency (n%) |
|---|---|
| Cases | 378 (48.8) |
| Allergy | 178 (47.1) |
| Intolerance | 82 (21.7) |
| Allergy, and intolerance | 13 (3.4) |
| Allergy and IBS | 63 (16.7) |
| Intolerance, and IBS | 35 (9.6) |
| IBS | 4(1.1) |
| Allergy, intolerance, and IBS | 3 (0.8) |
| Characteristics | Case (n=378) N(%) |
Control (n=397) N (%) |
p-Value | Total (n=775) N (%) |
|
|---|---|---|---|---|---|
| Gender | |||||
| Male | 185 (48.4) | 197 (51.6) | 0.850 | 382 (49.3) | |
| Female | 193 (49.1) | 200 (50.9) | 393 (50.7) | ||
| Age (years), mean ± SD | 38.8±0.16 | 38.9±0.15 | 0.902 | 775 (100) | |
| Crowding index*, mean ± SD | 1.48±0.17 | 1.53±0.17 | 0.259 | 775 (100) | |
| Governorate of residence | |||||
| Akkar | 15 (4) | 24 (6) | 0.03 | 39 (5) | |
| Baalbek-Hermel | 21(5.6) | 34 (8.7) | 55 (7.1) | ||
| Beirut | 139(36.8) | 101 (25.4) | 240 (31) | ||
| Bekaa | 16(4.2) | 24 (6) | 40 (5.1) | ||
| Mount Lebanon | 128 (34) | 135 (34) | 263 (34) | ||
| Nabatieh | 15 (4) | 21 (5.3) | 36 (4.6) | ||
| North Lebanon | 21 (5.6) | 26 (6.6) | 47 (6.1) | ||
| South Lebanon | 23 (5.8) | 32 (8) | 55 (7.1) | ||
| Level of education | |||||
| Elementary School | 27 (7.1) | 35 (8.8) | 0.160 | 62 (8) | |
| Middle School | 46 (12.2) | 61 (15.4) | 107 (13.8) | ||
| High School | 46 (12.2) | 60 (15.1) | 106 (13.7) | ||
| University/Higher Education | 259 (68.5) | 241 (60.7) | 500 (64.5) | ||
| Employment status | |||||
| Student | 24 (6.3) | 28 (7.1) | 0.181 | 52 (6.7) | |
| Not working | 155 (41) | 130 (32.7) | 285 (36.8) | ||
| Employed | 80(23.8) | 100 (25.2) | 180 (23.2) | ||
| Self Employed | 80 (21.2) | 104 (26.2) | 184 (23.7) | ||
| Retired | 29 (7.7) | 35 (8.8) | 64 (8.2) | ||
| Marital status | |||||
| Single | 227 (60.1) | 208 (52.4) | 0.133 | 435 (56.1) | |
| Married | 144 (38.1) | 177 (44.6) | 321 (41.4) | ||
| Divorced | 6 (1.6) | 8 (2) | 14 (1.8) | ||
| Separated | 1 (0.3) | 1 (0.3) | 2 (0.3) | ||
| Widowed | 0 (0) | 3 (0.8) | 3 (0.4) | ||
| Characteristics | Case (n=378) N(%) | Control (n=397) N(%) | p-Value | Total (n=775) N (%) |
|---|---|---|---|---|
| Diseases | ||||
| Hypertention | 51 (13.5) | 66 (16.6) | 0.223 | 117 (15.1) |
| Type 2 diabetes | 23 (6.1) | 25 (6.3) | 0.902 | 48 (6.2) |
| Dyslipidemia | 33 (8.7) | 38 (9.6) | 0.685 | 71 (9.2) |
| Cardiovascular diseases | 17 (4.5) | 18 (4.5) | 0.980 | 35 (4.5) |
| Renal Diseases | 23 (6.1) | 26 (6.5) | 0.791 | 49 (6.3) |
| Liver Diseases | 9 (2.4) | 12 (3) | 0.582 | 21 (2.7) |
| Cancer | 7 (1.9) | 9 (2.3) | 0.685 | 16 (2.1) |
| Immunodeficiency | 12 (3.2) | 16 (4) | 0.523 | 28 (3.6) |
| Pulmonary diseases | 9 (2.4) | 12 (3) | 0.582 | 21 (2.7) |
| Autoimmune diseases | 66 (17.5) | 6 (1.5) | 0.000 | 72 (9.2) |
| Rheumatoid arthritis | 17 (4.5) | 2 (0.5) | 0.000 | 19 (2.5) |
| Hashimoto | 15 (4) | 2 (0.5) | 0.001 | 17 (2.2) |
| Lupus | 1 (0.3) | 0 (0) | 0.488 | 1 (0.12) |
| Crohn’s disease | 15 (4) | 0 (0) | 0.000 | 15 (1.93) |
| Ulcerative colitis | 1 (0.3) | 0 (0) | 0.488 | 1 (0.12) |
| Multiple sclerosis | 1 (0.3) | 0 (0) | 0.488 | 1 (0.12) |
| Type 1 diabetes | 1 (0.3) | 0 (0) | 0.972 | 1 (0.12) |
| Psoriasis | 10 (2.6) | 1 (0.3) | 0.005 | 11 (1.41) |
| Grave’s disease | 1 (0.3) | 0 (0) | 0.488 | 1 (0.1) |
| Celiac disease | 4 (1.1) | 0 (0) | 0.056 | 4 (0.5) |
| Smoking status (yes) | 140 (37) | 120 (30.2) | 0.000 | 260 (33.5) |
| Type of smoking | ||||
| Argileh (yes) | 42 (11.1) | 36 (9.1) | 0.816 | 78 (10.06) |
| Cigarette (yes) | 61 (16.1) | 50 (12.6) | 111 (14.3) | |
| E-Cigarette (yes) | 71 (18.8) | 48 (19.6) | 119 (15.35) | |
| Physical activity (yes) | ||||
| Vigorous | 28 (7.4) | 38 (9.6) | 0.993 | 66 (8.5) |
| Moderate | 35 (9.3) | 55 (13.8) | 0.845 | 90 (11.6) |
| BMI (Kg/m2) mean ± SD | 29.13 ± 0.1 | 28.57±0.1 | 0.426 | 775 (100) |
| Biochemical testing | ||||
| Hematocrit (%) | ||||
| Men | 45.1 ± 0.04 | 45.2 ± 0.04 | 0.851 | |
| Women | 40.7 ± 0.05 | 41.71 ± 0.03 | 0.006 | |
| Hemoglobin (g/dl) | ||||
| Men | 14.54 ± 0.04 | 14.98 ± 0.03 | 0.001 | |
| Women | 13.51 ± 0.05 | 13.73 ± 0.03 | 0.082 | |
| Folic Acid (ng/ml) | 9.18± 0.21 | 9.70±0.20 | 0.106 | |
| VitB12 (pg/ml) | 478.3 ±0.24 | 516.7±0.21 | 0.04 | |
| VitD (ng/ml) | 52.2±0.29 | 60.30±0.24 | 0.001 | |
| Ferritin (ng/ml) | ||||
| Men | 55.81 ± 0.35 | 56.08 ± 0.36 | 0.954 | |
| Women | 55.79 ± 0.35 | 59.56 ± 0.33 | 0.415 | |
| Coproculture | 16 (4.23) |
42 (17.2) |
0.001 |
58 (7.48) |
| Positive bacterial infection | ||||
| Positive fungal infection | 65 (17.1) | 55 (13.9) | 0.001 | 120 (15.48) |
| Positive parasitic infection | 66 (17.5) | 32 (8.1) | 0.016 | 98 (12.64) |
| Positive Calprotectin | 87 (23) | 32 (8.1) | 0.000 | 119 (15.35) |
| Characteristic | Cases (n = 378) Mean ± SD | Controls (n = 397) Mean ± SD |
RDA | p-value (Case vs Control) | p-value (Case vs RDA) | p-value (Control vs RDA) | Total (n=775) N (%) |
|
|---|---|---|---|---|---|---|---|---|
| Energy (kcal/day) Male Female |
2339 ± 0.2 2359±0.2 2320±0.2 |
2535 ± 0.2 | 2500 (M), 2000 (F) | 0.003 <0.001 0.810 |
<0.001 | <0.001 |
775 (100) |
|
| Protein (g/day) | 53 ± 0.2 | 58 ± 0.2 | 50 | <0.001 | <0.001 | <0.001 | ||
| Carbohydrates (g/day) | 285 ± 0.2 | 314 ± 0.2 | 275 | <0.001 | <0.001 | <0.001 | ||
| Fat (g/day) | 81 ± 0.1 | 89 ± 0.2 | 70–78 | <0.001 | <0.001 | <0.001 | ||
| Calcium (mg/day) | 1043 ± 0.2 | 1139 ± 0.04 | 1000 | 0.001 | <0.001 | <0.001 | ||
| Iron (mg/day) | 12.6 ± 0.2 | 13.7 ± 0.2 | 12 | 0.023 | <0.001 | <0.001 | ||
| Potassium (mg/day) | 3094 ± 0.2 | 3358 ± 0.2 | 3000 | 0.002 | <0.001 | <0.001 | ||
| Sodium (mg/day) | 1549 ± 0.02 | 1552 ± 0.02 | 1500 | 0.644 | <0.001 | <0.001 | ||
| Vitamin A (µg/day) | 797 ± 0.04 | 799 ± 0.04 | 800 | 0.714 | 0.984 | 0.467 | ||
| Vitamin C (mg/day) | 86 ± 0.2 | 94 ± 0.2 | 82 | <0.001 | <0.001 | <0.001 | ||
| Vitamin D (µg/day) | 16 ± 0.1 | 17 ± 0.2 | 15 | 0.001 | <0.001 | <0.001 | ||
| Vitamin E (mg/day) | 16 ± 0.2 | 17 ± 0.2 | 15 | 0.001 | <0.001 | <0.001 | ||
| Vitamin K (µg/day) | 109 ± 0.2 | 118 ± 0.2 | 105 | 0.002 | <0.001 | <0.001 | ||
| Folate (µg/day) | 419 ± 0.2 | 452 ± 0.2 | 400 | 0.003 | <0.001 | <0.001 | ||
| Vitamin B12 (µg/day) | 2.5 ± 0.2 | 2.8 ± 0.2 | 2.4 | <0.001 | <0.001 | <0.001 | ||
| Magnesium (mg/day) | 367 ± 0.2 | 400 ± 0.2 | 350 | 0.001 | <0.001 | <0.001 | ||
| Zinc (mg/day) | 9.7 ± 0.2 | 10.7 ± 0.2 | 9.5 | 0.001 | <0.001 | <0.001 | ||
| Lactose (g/day) | 12.4 ± 0.2 | 13.6 ± 0.2 | 12 | <0.001 | <0.001 | <0.001 | ||
| Sugar (g/day) | 32 ± 0.2 | 34 ± 0.2 | 25–36 | 0.007 | <0.001 | <0.001 | ||
| Fiber (g/day) | 29 ± 0.2 | 31 ± 0.2 | 30 | 0.005 | 0.212 | <0.001 |
| Characteristics | Case (n=378) N (%) |
Control (n=397) N (%) | p-Value | Total (n=775) N (%) |
|---|---|---|---|---|
| Skin symptoms | ||||
| Itching | 130 (34.4) | 59 (14.9) | 0.000 | 189 (24.4) |
| Redness | 145 (38.4) | 45 (11.3) | 0.000 | 190 (24.5) |
| Bumpy texture | 170 (45) | 59 (14.9) | 0.000 | 229 (29.5) |
| Dryness | 169 (44.7) | 59 (14.9) | 0.000 | 228 (29.4) |
| Swelling | 161 (42.6) | 61 (15.4) | 0.000 | 222 (28.6) |
| Nasal symptoms | ||||
| Nasal congestion, or rub | 181 (39.7) | 31 (7.8) | 0.000 | 181 (23.4) |
| Bad breath | 165 (43.7) | 73 (18.4) | 0.000 | 238 (30.7) |
| Headaches | 254 (67.2) | 243 (61.2) | 0.085 | 497 (64.1) |
| Fatigue/irritability | 168 (44.4) | 156 (39.3) | 0.166 | 324 (41.8) |
| Red eyes | 169 (44.7) | 15 (3.8) | 0.000 | 184 (23.7) |
| Snoring | 151 (39.9) | 15 (3.8) | 0.000 | 166 (21.4) |
| Itchy eyes | 170 (45) | 31 (7.8) | 0.000 | 201 (25.9) |
| Mouth breathing, or sneezing | 179 (47.4) | 46 (11.6) | 0.000 | 225 (29) |
| Runny nose | 171 (45.2) | 32 (8.1) | 0.000 | 203 (26.2) |
| Sinus infection | 174 (46) | 76 (19.1) | 0.000 | 250 (32.3) |
| Discolored Drainage | 169 (44.7) | 122 (30.7 | 0.000 | 291 (37.5) |
| Loss of taste and smell | 164 (43.4) | 106 (26.7) | 0.000 | 270 (34.8) |
| Respiratory symptoms | ||||
| Cough | 174 (46) | 29 (7.3) | 0.000 | 203 (26.2) |
| Cough from postnasal drip | 142 (37.6) | 16 (4) | 0.000 | 158 (20.4) |
| Tightness | 92 (35.7) | 16 (4) | 0.000 | 151 (19.5) |
| Quincke oedema | 38 (10.1) | 15 (3.8) | 0.001 | 53 (6.8) |
| Gastric symptoms | ||||
| Diarrhea | 76 (20.1) | 31 (7.8) | 0.000 | 107 (13.8) |
| Constipation | 91 (24.1) | 62 (15.6) | 0.004 | 153 (19.7) |
| Vomiting | 52 (13.7) | 16 (4) | 0.000 | 68 (8.8) |
| Heartburn | 85 (22.5) | 45 (11.3) | 0.000 | 130 (16.8) |
| Reflux | 107 (28.3) | 122 (30.7) | 0.479 | 229 (29.5) |
| Bloating | 157 (41.5) | 123 (31) | 0.003 | 280 (36.1) |
| Flatulence | 116 (30.6) | 124 (31.2) | 0.877 | 240 (31) |
| Nausea | 96 (25.4) | 32 (8.1) | 0.000 | 128 (16.5) |
| Characteristics | Case (n=378) N (%) |
Control (n=397) N (%) |
p-Value | Participants frequency n (%) |
|---|---|---|---|---|
| 0.831 | ||||
| Low and Moderate | 293 (77.5) | 309 (77.7) | 602 (77.7) | |
| High | 85 (22.4) | 88 (22.1) | 173 (22.3) | |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).